Compare Rex Fang & Innovation Equity Premium Income ETF (FEPI) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rex Fang & Innovation Equity Premium Income ETF vs Oruka Therapeutics Inc. Common Stock — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $41.66 (market cap $753.07M), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 6.7× Rex Fang & Innovation Equity Premium Income ETF's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Rex Fang & Innovation Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rex Fang & Innovation Equity Premium Income ETF for 57 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| FEPI | ORKA | |
|---|---|---|
Market Cap | $753.07M | $5.08B |
Volume | 329,956 | 685,276 |
Sector | Income / Options Overlay | Health |
52-Week High | $49.54 | $113.08 |
52-Week Low | $37.98 | $26.19 |
Typical Hold Time | 57 Days | 0 Days |
Enterprise Value | — | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $43.28, showing minimal daily movement with a 0.14% gain. The ETF employs a covered call strategy on AI and mega-cap tech stocks, generating substantial weekly dividends averaging $0.20-0.21 per distribution. Technical indicators show a bullish trend with strong moving average support, though oscillators remain neutral. The fund's high-yield approach provides consistent income but faces challenges in total return performance compared to peers.
FEPI offers investors a high-yield income stream through its covered call strategy, currently yielding approximately 25%. However, the fund's concentrated tech exposure and capped upside potential present significant risks during market volatility. While the weekly dividend structure appeals to income-focused investors, total return underperformance and dependence on tech sector stability warrant careful consideration for long-term positioning.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Rex Fang & Innovation Equity Premium Income ETF
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
